Ryvu Therapeutics Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	541	627	890	1,329	1,139	1,120
Market Cap Growth	17.12%	-29.61%	-33.04%	16.75%	1.70%	23.98%
Enterprise Value	529	585	755	1,082	1,098	1,035
Last Close Price	23.40	27.10	38.50	57.50	49.25	61.00
PS Ratio	6.17	7.14	8.73	19.76	16.64	31.62
PB Ratio	10.05	11.64	5.85	5.12	3.32	6.94
P/TBV Ratio	11.32	13.11	6.17	5.25	3.36	7.08
P/FCF Ratio	-	-	-	-	75.58	-
P/OCF Ratio	-	-	-	-	53.41	-
PEG Ratio	-	3.41	3.41	3.41	3.41	3.41
EV/Sales Ratio	6.03	6.67	7.41	16.08	16.05	29.21
EV/FCF Ratio	-4.35	-	-	-	72.90	-
Debt / Equity Ratio	1.78	1.78	0.67	0.04	0.04	0.08
Debt / FCF Ratio	-	-	-	-	0.84	-
Net Debt / Equity Ratio	-0.22	-0.22	-0.81	-0.86	-0.26	-0.46
Net Debt / EBITDA Ratio	0.13	0.13	1.11	2.56	1.54	1.11
Net Debt / FCF Ratio	0.10	0.10	0.92	2.40	-5.96	1.06
Asset Turnover	0.29	0.29	0.26	0.15	0.19	0.14
Inventory Turnover	11.63	11.63	11.77	9.06	9.37	7.56
Quick Ratio	2.08	2.08	2.42	3.82	8.09	2.76
Current Ratio	2.26	2.26	2.52	3.99	8.21	2.88
Return on Equity (ROE)	-98.22%	-98.22%	-54.11%	-30.55%	-33.20%	-41.08%
Return on Assets (ROA)	-20.14%	-20.14%	-19.50%	-13.86%	-12.34%	-18.80%
Return on Invested Capital (ROIC)	-270.37%	-275.62%	-380.19%	-67.32%	-40.89%	-101.00%
Return on Capital Employed (ROCE)	-59.70%	-59.70%	-45.00%	-29.20%	-16.20%	-41.00%
Earnings Yield	-18.71%	-16.16%	-12.52%	-6.93%	-7.36%	-7.06%
FCF Yield	-22.47%	-19.40%	-15.21%	-7.00%	1.32%	-6.33%
Buyback Yield / Dilution	-	-	-0.97%	-24.75%	-	-9.48%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.